首页 > 最新文献

World journal of nephrology最新文献

英文 中文
Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. 揭示上皮细胞向间质转化在糖尿病肾病中的病理作用:错综复杂的联系与多方面的机制。
Pub Date : 2024-06-25 DOI: 10.5527/wjn.v13.i2.95410
Pitchai Balakumar

Renal epithelial-to-mesenchymal transition (EMT) is a process in which epithelial cells undergo biochemical changes and transform into mesenchymal-like cells, resulting in renal abnormalities, including fibrosis. EMT can cause diabetic nephropathy through triggering kidney fibrosis, inflammation, and functional impairment. The diverse molecular pathways that drive EMT-mediated renal fibrosis are not utterly known. Targeting key signaling pathways involved in EMT may help ameliorate diabetic nephropathy and improve renal function. In such settings, understanding precisely the complicated signaling networks is critical for developing customized therapies to intervene in EMT-mediated diabetic nephropathy.

肾脏上皮细胞向间充质细胞转化(EMT)是上皮细胞发生生化变化并转化为间充质样细胞的过程,从而导致肾脏异常,包括纤维化。EMT 可引发肾脏纤维化、炎症和功能损害,从而导致糖尿病肾病。目前还不完全清楚驱动 EMT 介导的肾脏纤维化的各种分子通路。靶向参与 EMT 的关键信号通路可能有助于改善糖尿病肾病并改善肾功能。在这种情况下,准确了解复杂的信号网络对于开发干预 EMT 介导的糖尿病肾病的定制疗法至关重要。
{"title":"Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism.","authors":"Pitchai Balakumar","doi":"10.5527/wjn.v13.i2.95410","DOIUrl":"10.5527/wjn.v13.i2.95410","url":null,"abstract":"<p><p>Renal epithelial-to-mesenchymal transition (EMT) is a process in which epithelial cells undergo biochemical changes and transform into mesenchymal-like cells, resulting in renal abnormalities, including fibrosis. EMT can cause diabetic nephropathy through triggering kidney fibrosis, inflammation, and functional impairment. The diverse molecular pathways that drive EMT-mediated renal fibrosis are not utterly known. Targeting key signaling pathways involved in EMT may help ameliorate diabetic nephropathy and improve renal function. In such settings, understanding precisely the complicated signaling networks is critical for developing customized therapies to intervene in EMT-mediated diabetic nephropathy.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 2","pages":"95410"},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11229833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renoprotective strategies. 肾脏保护策略
Pub Date : 2024-03-25 DOI: 10.5527/wjn.v13.i1.89637
Vaia D Raikou

Kidney disease remains a condition with an increasing incidence, high morbidity and mortality associated with cardiovascular events. The incidence of end-stage renal disease is expected to increase. Despite of the technical improvement, dialysis never achieved a full clearance of the blood dialysis. Therefore, the demand for new renoprotective measures has never been greater. Here, we report new strategies for preventing renal damage.

肾脏疾病的发病率不断上升,发病率和死亡率居高不下,并与心血管事件密切相关。预计终末期肾病的发病率还会增加。尽管透析技术不断改进,但透析始终无法完全清除血液中的透析物。因此,对新的肾脏保护措施的需求空前强烈。在此,我们报告了预防肾损伤的新策略。
{"title":"Renoprotective strategies.","authors":"Vaia D Raikou","doi":"10.5527/wjn.v13.i1.89637","DOIUrl":"https://doi.org/10.5527/wjn.v13.i1.89637","url":null,"abstract":"<p><p>Kidney disease remains a condition with an increasing incidence, high morbidity and mortality associated with cardiovascular events. The incidence of end-stage renal disease is expected to increase. Despite of the technical improvement, dialysis never achieved a full clearance of the blood dialysis. Therefore, the demand for new renoprotective measures has never been greater. Here, we report new strategies for preventing renal damage.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 1","pages":"89637"},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges with non-descriptive compliance labeling of end-stage renal disease patients in accessibility for renal transplantation. 肾移植终末期肾病患者无障碍遵医嘱标签的挑战。
Pub Date : 2024-03-25 DOI: 10.5527/wjn.v13.i1.88967
Benjamin Peticca, Tomas M Prudencio, Samuel G Robinson, Sunil S Karhadkar

Non-descriptive and convenient labels are uninformative and unfairly project blame onto patients. The language clinicians use in the Electronic Medical Record, research, and clinical settings shapes biases and subsequent behaviors of all providers involved in the enterprise of transplantation. Terminology such as noncompliant and nonadherent serve as a reason for waitlist inactivation and limit access to life-saving transplantation. These labels fail to capture all the circumstances surrounding a patient's inability to follow their care regimen, trivialize social determinants of health variables, and bring unsubstantiated subjectivity into decisions regarding organ allocation. Furthermore, insufficient Medicare coverage has forced patients to ration or stop taking medication, leading to allograft failure and their subsequent diagnosis of noncompliant. We argue that perpetuating non-descriptive language adds little substantive information, increases subjectivity to the organ allocation process, and plays a major role in reduced access to transplantation. For patients with existing barriers to care, such as racial/ethnic minorities, these effects may be even more drastic. Transplant committees must ensure thorough documentation to correctly encapsulate the entirety of a patient's position and give voice to an already vulnerable population.

非描述性的便捷标签无法提供信息,而且会不公平地将责任推给患者。临床医生在电子病历、研究和临床环境中使用的语言会影响参与移植事业的所有医疗人员的偏见和后续行为。不合规和不依从等术语成为等待者名单失效的理由,并限制了患者获得救命的移植手术。这些标签无法捕捉到患者无法遵守护理方案的所有情况,轻视了健康的社会决定因素变量,并将未经证实的主观性带入了有关器官分配的决策中。此外,医疗保险覆盖范围不足也迫使患者减少或停止服药,导致异体移植失败,并随后被诊断为不遵医嘱。我们认为,非描述性语言的长期存在几乎没有增加实质性信息,增加了器官分配过程的主观性,并在减少移植机会方面发挥了重要作用。对于那些在治疗方面存在障碍的患者,如少数民族患者,这些影响可能更为严重。移植委员会必须确保详尽的文件记录,以正确概括患者的全部立场,并为本已脆弱的人群提供发言权。
{"title":"Challenges with non-descriptive compliance labeling of end-stage renal disease patients in accessibility for renal transplantation.","authors":"Benjamin Peticca, Tomas M Prudencio, Samuel G Robinson, Sunil S Karhadkar","doi":"10.5527/wjn.v13.i1.88967","DOIUrl":"https://doi.org/10.5527/wjn.v13.i1.88967","url":null,"abstract":"<p><p>Non-descriptive and convenient labels are uninformative and unfairly project blame onto patients. The language clinicians use in the Electronic Medical Record, research, and clinical settings shapes biases and subsequent behaviors of all providers involved in the enterprise of transplantation. Terminology such as <i>noncompliant</i> and <i>nonadherent</i> serve as a reason for waitlist inactivation and limit access to life-saving transplantation. These labels fail to capture all the circumstances surrounding a patient's inability to follow their care regimen, trivialize social determinants of health variables, and bring unsubstantiated subjectivity into decisions regarding organ allocation. Furthermore, insufficient Medicare coverage has forced patients to ration or stop taking medication, leading to allograft failure and their subsequent diagnosis of <i>noncompliant</i>. We argue that perpetuating non-descriptive language adds little substantive information, increases subjectivity to the organ allocation process, and plays a major role in reduced access to transplantation. For patients with existing barriers to care, such as racial/ethnic minorities, these effects may be even more drastic. Transplant committees must ensure thorough documentation to correctly encapsulate the entirety of a patient's position and give voice to an already vulnerable population.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 1","pages":"88967"},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring kidney biopsy findings in congenital heart diseases: Insights beyond cyanotic nephropathy. 探索先天性心脏病的肾活检结果:超越紫绀型肾病的见解。
Pub Date : 2024-03-25 DOI: 10.5527/wjn.v13.i1.88972
Jose Daniel Juarez-Villa, Iván Zepeda-Quiroz, Sebastián Toledo-Ramírez, Victor Hugo Gomez-Johnson, Francisco Pérez-Allende, Brian Ricardo Garibay-Vega, Francisco E Rodríguez Castellanos, Bernardo Moguel-González, Edgar Garcia-Cruz, Salvador Lopez-Gil

Background: The association between congenital heart disease and chronic kidney disease is well known. Various mechanisms of kidney damage associated with congenital heart disease have been established. The etiology of kidneydisease has commonly been considered to be secondary to focal segmental glomerulosclerosis (FSGS), however, this has only been demonstrated in case reports and not in observational or clinical trials.

Aim: To identify baseline and clinical characteristics, as well as the findings in kidney biopsies of patients with congenital heart disease in our hospital.

Methods: This is a retrospective observational study conducted at the Nephrology Department of the National Institute of Cardiology "Ignacio Chávez". All patients over 16 years old who underwent percutaneous kidney biopsy from January 2000 to January 2023 with congenital heart disease were included in the study.

Results: Ten patients with congenital heart disease and kidney biopsy were found. The average age was 29.00 years ± 15.87 years with pre-biopsy proteinuria of 6193 mg/24 h ± 6165 mg/24 h. The most common congenital heart disease was Fallot's tetralogy with 2 cases (20%) and ventricular septal defect with 2 (20%) cases. Among the 10 cases, one case of IgA nephropathy and one case of membranoproliferative glomerulonephritis associated with immune complexes were found, receiving specific treatment after histopathological diagnosis, delaying the initiation of kidney replacement therapy. Among remaining 8 cases (80%), one case of FSGS with perihilar variety was found, while the other 7 cases were non-specific FSGS.

Conclusion: Determining the cause of chronic kidney disease can help in delaying the need for kidney replacement therapy. In 2 out of 10 patients in our study, interventions were performed, and initiation of kidney replacement therapy was delayed. Prospective studies are needed to determine the usefulness of kidney biopsy in patients with congenital heart disease.

背景:先天性心脏病与慢性肾脏病之间的关系众所周知。与先天性心脏病相关的肾脏损伤机制多种多样。肾脏疾病的病因通常被认为是继发于局灶节段性肾小球硬化症(FSGS),但这只在病例报告中得到证实,而未在观察性或临床试验中得到证实:这是一项在 "伊格纳西奥-查韦斯 "国家心脏病研究所肾脏内科进行的回顾性观察研究。研究对象包括 2000 年 1 月至 2023 年 1 月期间接受经皮肾活检的所有 16 岁以上先天性心脏病患者:结果:共发现 10 名患有先天性心脏病并接受过肾活检的患者。最常见的先天性心脏病是法洛氏四联症(2 例,占 20%)和室间隔缺损(2 例,占 20%)。在 10 个病例中,发现了 1 例 IgA 肾病和 1 例与免疫复合物相关的膜增生性肾小球肾炎,经组织病理学诊断后接受了特殊治疗,推迟了肾脏替代治疗的开始时间。其余 8 例病例(80%)中,1 例为肾周型 FSGS,其余 7 例为非特异性 FSGS:结论:确定慢性肾脏病的病因有助于推迟肾脏替代治疗的时间。在我们的研究中,10 例患者中有 2 例进行了干预,推迟了肾脏替代治疗的开始时间。需要进行前瞻性研究,以确定肾活检在先天性心脏病患者中的作用。
{"title":"Exploring kidney biopsy findings in congenital heart diseases: Insights beyond cyanotic nephropathy.","authors":"Jose Daniel Juarez-Villa, Iván Zepeda-Quiroz, Sebastián Toledo-Ramírez, Victor Hugo Gomez-Johnson, Francisco Pérez-Allende, Brian Ricardo Garibay-Vega, Francisco E Rodríguez Castellanos, Bernardo Moguel-González, Edgar Garcia-Cruz, Salvador Lopez-Gil","doi":"10.5527/wjn.v13.i1.88972","DOIUrl":"https://doi.org/10.5527/wjn.v13.i1.88972","url":null,"abstract":"<p><strong>Background: </strong>The association between congenital heart disease and chronic kidney disease is well known. Various mechanisms of kidney damage associated with congenital heart disease have been established. The etiology of kidneydisease has commonly been considered to be secondary to focal segmental glomerulosclerosis (FSGS), however, this has only been demonstrated in case reports and not in observational or clinical trials.</p><p><strong>Aim: </strong>To identify baseline and clinical characteristics, as well as the findings in kidney biopsies of patients with congenital heart disease in our hospital.</p><p><strong>Methods: </strong>This is a retrospective observational study conducted at the Nephrology Department of the National Institute of Cardiology \"Ignacio Chávez\". All patients over 16 years old who underwent percutaneous kidney biopsy from January 2000 to January 2023 with congenital heart disease were included in the study.</p><p><strong>Results: </strong>Ten patients with congenital heart disease and kidney biopsy were found. The average age was 29.00 years ± 15.87 years with pre-biopsy proteinuria of 6193 mg/24 h ± 6165 mg/24 h. The most common congenital heart disease was Fallot's tetralogy with 2 cases (20%) and ventricular septal defect with 2 (20%) cases. Among the 10 cases, one case of IgA nephropathy and one case of membranoproliferative glomerulonephritis associated with immune complexes were found, receiving specific treatment after histopathological diagnosis, delaying the initiation of kidney replacement therapy. Among remaining 8 cases (80%), one case of FSGS with perihilar variety was found, while the other 7 cases were non-specific FSGS.</p><p><strong>Conclusion: </strong>Determining the cause of chronic kidney disease can help in delaying the need for kidney replacement therapy. In 2 out of 10 patients in our study, interventions were performed, and initiation of kidney replacement therapy was delayed. Prospective studies are needed to determine the usefulness of kidney biopsy in patients with congenital heart disease.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 1","pages":"88972"},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point of care ultrasonography as the new "Laennec Sthetoscope". 作为新型 "Laennec 缝合镜 "的护理点超声波检查。
Pub Date : 2024-03-25 DOI: 10.5527/wjn.v13.i1.90542
Ernesto Sabath

Point of care ultrasonography (POCUS) has evolved to become the fifth pillar of the conventional physical examination, and use of POCUS protocols have significantly decreased procedure complications and time to diagnose. However, lack of experience in POCUS by preceptors in medical schools and nephrology residency programs are significant barriers to implement a broader use. In rural and low-income areas POCUS may have a transformative effect on health care management.

护理点超声检查(POCUS)已发展成为传统体格检查的第五大支柱,POCUS 协议的使用大大减少了手术并发症和诊断时间。然而,医学院和肾脏病住院医师培训项目中的实习医生缺乏 POCUS 经验,这是更广泛使用 POCUS 的重大障碍。在农村和低收入地区,POCUS 可能会对医疗保健管理产生变革性影响。
{"title":"Point of care ultrasonography as the new \"Laennec Sthetoscope\".","authors":"Ernesto Sabath","doi":"10.5527/wjn.v13.i1.90542","DOIUrl":"https://doi.org/10.5527/wjn.v13.i1.90542","url":null,"abstract":"<p><p>Point of care ultrasonography (POCUS) has evolved to become the fifth pillar of the conventional physical examination, and use of POCUS protocols have significantly decreased procedure complications and time to diagnose. However, lack of experience in POCUS by preceptors in medical schools and nephrology residency programs are significant barriers to implement a broader use. In rural and low-income areas POCUS may have a transformative effect on health care management.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 1","pages":"90542"},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological features and medium-term outcomes of histologic variants of primary focal segmental glomerulosclerosis in adults: A retrospective study. 成人原发性局灶节段性肾小球硬化症组织学变异的临床病理特征和中期疗效:一项回顾性研究。
Pub Date : 2024-03-25 DOI: 10.5527/wjn.v13.i1.88028
Nazarul Hassan Jafry, Shumaila Manan, Rahma Rashid, Muhammed Mubarak

Background: The Columbia classification identified five histological variants of focal segmental glomerulosclerosis (FSGS). The prognostic significance of these variants remains controversial.

Aim: To evaluate the relative frequency, clinicopathologic characteristics, and medium-term outcomes of FSGS variants at a single center in Pakistan.

Methods: This retrospective study was conducted at the Department of Nephrology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan on all consecutive adults (≥ 16 years) with biopsy-proven primary FSGS from January 1995 to December 2017. Studied subjects were treated with steroids as a first-line therapy. The response rates, doubling of serum creatinine, and kidney failure (KF) with replacement therapy were compared between histological variants using ANOVA or Kruskal Wallis, and Chi-square tests as appropriate. Data were analyzed by SPSS version 22.0. P-value ≤ 0.05 was considered significant.

Results: A total of 401 patients were diagnosed with primary FSGS during the study period. Among these, 352 (87.7%) had a designated histological variant. The not otherwise specified (NOS) variant was the commonest, being found in 185 (53.9%) patients, followed by the tip variant in 100 (29.1%) patients. Collapsing (COL), cellular (CEL), and perihilar (PHI) variants were seen in 58 (16.9%), 6 (1.5%), and 3 (0.7%) patients, respectively. CEL and PHI variants were excluded from further analysis due to small patient numbers. The mean follow-up period was 36.5 ± 29.2 months. Regarding response rates of variants, patients with TIP lesions achieved remission more frequently (59.5%) than patients with NOS (41.8%) and COL (24.52%) variants (P < 0.001). The hazard ratio of complete response among patients with the COL variant was 0.163 [95% confidence interval (CI): 0.039-0.67] as compared to patients with NOS. The TIP variant showed a hazard ratio of 2.5 (95%CI: 1.61-3.89) for complete remission compared to the NOS variant. Overall, progressive KF was observed more frequently in patients with the COL variant, 43.4% (P < 0.001). Among these, 24.53% of patients required kidney replacement therapy (P < 0.001). The hazard ratio of doubling of serum creatinine among patients with the COL variant was 14.57 (95%CI: 1.87-113.49) as compared to patients with the TIP variant.

Conclusion: In conclusion, histological variants of FSGS are predictive of response to treatment with immunosuppressants and progressive KF in adults in our setup.

背景:哥伦比亚分类确定了局灶节段性肾小球硬化症(FSGS)的五种组织学变异。目的:评估巴基斯坦一个中心的 FSGS 变异的相对频率、临床病理特征和中期预后:这项回顾性研究是在巴基斯坦卡拉奇信德泌尿外科和移植研究所肾脏病学系进行的,研究对象是 1995 年 1 月至 2017 年 12 月期间所有经活检证实的原发性 FSGS 连续成人患者(≥ 16 岁)。研究对象接受类固醇作为一线疗法。根据情况使用方差分析或 Kruskal Wallis 检验和卡方检验比较了不同组织学变异之间的反应率、血清肌酐倍增和替代治疗后的肾衰竭(KF)。数据采用 SPSS 22.0 版进行分析。P值≤0.05为差异显著:研究期间共有 401 名患者被确诊为原发性 FSGS。其中,352 例(87.7%)有指定的组织学变异。最常见的是未注明变异型(NOS),在 185 例(53.9%)患者中发现,其次是尖端变异型,在 100 例(29.1%)患者中发现。塌陷型(COL)、细胞型(CEL)和周围型(PHI)变体分别出现在 58 名(16.9%)、6 名(1.5%)和 3 名(0.7%)患者中。由于患者人数较少,CEL 和 PHI 变体未被纳入进一步分析。平均随访时间为 36.5 ± 29.2 个月。关于变异体的反应率,TIP病变患者获得缓解的比例(59.5%)高于NOS(41.8%)和COL(24.52%)变异体患者(P < 0.001)。与 NOS 患者相比,COL 变异患者完全缓解的危险比为 0.163 [95% 置信区间 (CI):0.039-0.67]。与NOS变异型相比,TIP变异型患者完全缓解的危险比为2.5(95%置信区间:1.61-3.89)。总体而言,COL变异型患者中进行性KF的发生率更高,为43.4%(P < 0.001)。其中,24.53%的患者需要肾脏替代治疗(P < 0.001)。与TIP变异型患者相比,COL变异型患者血清肌酐翻倍的危险比为14.57(95%CI:1.87-113.49):总之,在我们的研究中,FSGS 的组织学变异可预测成人对免疫抑制剂治疗的反应和进展性 KF。
{"title":"Clinicopathological features and medium-term outcomes of histologic variants of primary focal segmental glomerulosclerosis in adults: A retrospective study.","authors":"Nazarul Hassan Jafry, Shumaila Manan, Rahma Rashid, Muhammed Mubarak","doi":"10.5527/wjn.v13.i1.88028","DOIUrl":"https://doi.org/10.5527/wjn.v13.i1.88028","url":null,"abstract":"<p><strong>Background: </strong>The Columbia classification identified five histological variants of focal segmental glomerulosclerosis (FSGS). The prognostic significance of these variants remains controversial.</p><p><strong>Aim: </strong>To evaluate the relative frequency, clinicopathologic characteristics, and medium-term outcomes of FSGS variants at a single center in Pakistan.</p><p><strong>Methods: </strong>This retrospective study was conducted at the Department of Nephrology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan on all consecutive adults (≥ 16 years) with biopsy-proven primary FSGS from January 1995 to December 2017. Studied subjects were treated with steroids as a first-line therapy. The response rates, doubling of serum creatinine, and kidney failure (KF) with replacement therapy were compared between histological variants using ANOVA or Kruskal Wallis, and Chi-square tests as appropriate. Data were analyzed by SPSS version 22.0. <i>P</i>-value ≤ 0.05 was considered significant.</p><p><strong>Results: </strong>A total of 401 patients were diagnosed with primary FSGS during the study period. Among these, 352 (87.7%) had a designated histological variant. The not otherwise specified (NOS) variant was the commonest, being found in 185 (53.9%) patients, followed by the tip variant in 100 (29.1%) patients. Collapsing (COL), cellular (CEL), and perihilar (PHI) variants were seen in 58 (16.9%), 6 (1.5%), and 3 (0.7%) patients, respectively. CEL and PHI variants were excluded from further analysis due to small patient numbers. The mean follow-up period was 36.5 ± 29.2 months. Regarding response rates of variants, patients with TIP lesions achieved remission more frequently (59.5%) than patients with NOS (41.8%) and COL (24.52%) variants (<i>P</i> < 0.001). The hazard ratio of complete response among patients with the COL variant was 0.163 [95% confidence interval (CI): 0.039-0.67] as compared to patients with NOS. The TIP variant showed a hazard ratio of 2.5 (95%CI: 1.61-3.89) for complete remission compared to the NOS variant. Overall, progressive KF was observed more frequently in patients with the COL variant, 43.4% (<i>P</i> < 0.001). Among these, 24.53% of patients required kidney replacement therapy (<i>P</i> < 0.001). The hazard ratio of doubling of serum creatinine among patients with the COL variant was 14.57 (95%CI: 1.87-113.49) as compared to patients with the TIP variant.</p><p><strong>Conclusion: </strong>In conclusion, histological variants of FSGS are predictive of response to treatment with immunosuppressants and progressive KF in adults in our setup.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 1","pages":"88028"},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and outcomes of polycystic kidney disease in African populations: A systematic review. 多囊肾病在非洲人群中的发病率和结果:系统综述。
Pub Date : 2024-03-25 DOI: 10.5527/wjn.v13.i1.90402
Modou Ndongo, Lot Motoula Nehemie, Baratou Coundoul, Abou Abdallah Malick Diouara, Sidy Mohamed Seck

Background: Polycystic kidney disease (PKD) is the most common genetic cause of kidney disease. It is a progressive and irreversible condition that can lead to end-stage renal disease and many other visceral complications. Current comprehensive data on PKD patterns in Africa is lacking.

Aim: To describe the prevalence and outcomes of PKD in the African population.

Methods: A literature search of PubMed, African journal online, and Google Scholar databases between 2000 and 2023 was performed. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses were followed to design the study. Clinical presentations and outcomes of patients were extracted from the included studies.

Results: Out of 106 articles, we included 13 studies from 7 African countries. Ten of them were retrospective descriptive studies concerning 943 PKD patients with a mean age of 47.9 years. The accurate prevalence and incidence of PKD were not known but it represented the third causal nephropathy among dialysis patients. In majority of patients, the diagnosis of the disease was often delayed. Kidney function impairment, abdominal mass, and hypertension were the leading symptoms at presentation with a pooled prevalence of 72.1% (69.1-75.1), 65.8% (62.2-69.4), and 57.4% (54.2-60.6) respectively. Hematuria and infections were the most frequent complications. Genotyping was performed in few studies that revealed a high proportion of new mutations mainly in the PKD1 gene.

Conclusion: The prevalence of PKD in African populations is not clearly defined. Clinical symptoms were almost present with most patients who had kidney function impairment and abdominal mass at the diagnostic. Larger studies including genetic testing are needed to determine the burden of PKD in African populations.

背景:多囊肾(PKD)是最常见的遗传性肾病。它是一种进行性和不可逆的疾病,可导致终末期肾病和许多其他内脏并发症。目的:描述PKD在非洲人群中的患病率和结果:方法:对2000年至2023年间的PubMed、非洲期刊在线和谷歌学术数据库进行文献检索。研究设计遵循《系统综述和元分析首选报告项目》。从纳入的研究中提取了患者的临床表现和结果:在 106 篇文章中,我们纳入了来自 7 个非洲国家的 13 项研究。其中10篇为回顾性描述性研究,涉及943名PKD患者,平均年龄为47.9岁。PKD的准确流行率和发病率尚不清楚,但它是透析患者中第三大致病性肾病。大多数患者的疾病诊断往往被延误。肾功能损害、腹部肿块和高血压是患者发病时的主要症状,总发病率分别为72.1%(69.1-75.1)、65.8%(62.2-69.4)和57.4%(54.2-60.6)。血尿和感染是最常见的并发症。少数研究进行了基因分型,结果显示,主要在PKD1基因中出现新突变的比例很高:结论:PKD在非洲人群中的发病率尚不明确。大多数患者在诊断时几乎都有肾功能损害和腹部肿块等临床症状。需要进行包括基因检测在内的更大规模的研究,以确定PKD在非洲人群中的发病率。
{"title":"Prevalence and outcomes of polycystic kidney disease in African populations: A systematic review.","authors":"Modou Ndongo, Lot Motoula Nehemie, Baratou Coundoul, Abou Abdallah Malick Diouara, Sidy Mohamed Seck","doi":"10.5527/wjn.v13.i1.90402","DOIUrl":"https://doi.org/10.5527/wjn.v13.i1.90402","url":null,"abstract":"<p><strong>Background: </strong>Polycystic kidney disease (PKD) is the most common genetic cause of kidney disease. It is a progressive and irreversible condition that can lead to end-stage renal disease and many other visceral complications. Current comprehensive data on PKD patterns in Africa is lacking.</p><p><strong>Aim: </strong>To describe the prevalence and outcomes of PKD in the African population.</p><p><strong>Methods: </strong>A literature search of PubMed, African journal online, and Google Scholar databases between 2000 and 2023 was performed. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses were followed to design the study. Clinical presentations and outcomes of patients were extracted from the included studies.</p><p><strong>Results: </strong>Out of 106 articles, we included 13 studies from 7 African countries. Ten of them were retrospective descriptive studies concerning 943 PKD patients with a mean age of 47.9 years. The accurate prevalence and incidence of PKD were not known but it represented the third causal nephropathy among dialysis patients. In majority of patients, the diagnosis of the disease was often delayed. Kidney function impairment, abdominal mass, and hypertension were the leading symptoms at presentation with a pooled prevalence of 72.1% (69.1-75.1), 65.8% (62.2-69.4), and 57.4% (54.2-60.6) respectively. Hematuria and infections were the most frequent complications. Genotyping was performed in few studies that revealed a high proportion of new mutations mainly in the <i>PKD1</i> gene.</p><p><strong>Conclusion: </strong>The prevalence of PKD in African populations is not clearly defined. Clinical symptoms were almost present with most patients who had kidney function impairment and abdominal mass at the diagnostic. Larger studies including genetic testing are needed to determine the burden of PKD in African populations.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"13 1","pages":"90402"},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moderate stepwise restriction of potassium intake to reduce risk of hyperkalemia in chronic kidney disease: A literature review. 适度逐步限制钾摄入以降低慢性肾脏疾病高钾血症的风险:一项文献综述。
Pub Date : 2023-09-25 DOI: 10.5527/wjn.v12.i4.73
Ali AlSahow

A potassium-rich diet has several cardiovascular and renal health benefits; however, it is not recommended for patients with advanced chronic kidney disease or end-stage kidney disease because of the risk of life-threatening hyperkalemia. To assess the strength of evidence supporting potassium intake restriction in chronic kidney disease, the medical literature was searched looking for the current recommended approach and for evidence in support for such an approach. There is a lack of strong evidence supporting intense restriction of dietary potassium intake. There are several ways to reduce potassium intake without depriving the patient from fruits and vegetables, such as identifying hidden sources of potassium (processed food and preservatives) and soaking or boiling food to remove potassium. An individualized and gradual reduction of dietary potassium intake in people at risk of hyperkalemia is recommended. The current potassium dietary advice in chronic kidney disease needs to be reevaluated, individualized, and gradually introduced.

富含钾的饮食对心血管和肾脏健康有很多好处;然而,它不建议用于晚期慢性肾脏疾病或终末期肾脏疾病的患者,因为有危及生命的高钾血症的风险。为了评估支持慢性肾脏疾病中限制钾摄入的证据的强度,检索了医学文献,寻找目前推荐的方法和支持这种方法的证据。缺乏强有力的证据支持严格限制饮食中的钾摄入。有几种方法可以在不剥夺患者水果和蔬菜的情况下减少钾的摄入,例如识别钾的隐藏来源(加工食品和防腐剂),以及浸泡或煮沸食物以去除钾。建议有高钾血症风险的人个体化并逐步减少饮食中的钾摄入量。目前慢性肾脏疾病的钾饮食建议需要重新评估、个性化并逐步引入。
{"title":"Moderate stepwise restriction of potassium intake to reduce risk of hyperkalemia in chronic kidney disease: A literature review.","authors":"Ali AlSahow","doi":"10.5527/wjn.v12.i4.73","DOIUrl":"https://doi.org/10.5527/wjn.v12.i4.73","url":null,"abstract":"<p><p>A potassium-rich diet has several cardiovascular and renal health benefits; however, it is not recommended for patients with advanced chronic kidney disease or end-stage kidney disease because of the risk of life-threatening hyperkalemia. To assess the strength of evidence supporting potassium intake restriction in chronic kidney disease, the medical literature was searched looking for the current recommended approach and for evidence in support for such an approach. There is a lack of strong evidence supporting intense restriction of dietary potassium intake. There are several ways to reduce potassium intake without depriving the patient from fruits and vegetables, such as identifying hidden sources of potassium (processed food and preservatives) and soaking or boiling food to remove potassium. An individualized and gradual reduction of dietary potassium intake in people at risk of hyperkalemia is recommended. The current potassium dietary advice in chronic kidney disease needs to be reevaluated, individualized, and gradually introduced.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"12 4","pages":"73-81"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1d/e6/WJN-12-73.PMC10520754.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41172689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoglobulin A vasculitis nephritis: Current understanding of pathogenesis and treatment. 免疫球蛋白A血管炎性肾炎:目前对发病机制和治疗的认识。
Pub Date : 2023-09-25 DOI: 10.5527/wjn.v12.i4.82
Michela Amatruda, Nicolina Stefania Carucci, Roberto Chimenz, Giovanni Conti

The clinical spectrum of immunoglobulin A vasculitis nephritis (IgAVN) ranges from the relatively common transitory microscopic hematuria and/or low-grade proteinuria to nephritic or nephrotic syndrome, rapidly progressive glomerulonephritis, or even renal failure. Clinical and experimental studies have shown a multifactor pathogenesis: Infection triggers, impaired glycosylation of IgA1, complement activation, Toll-like-receptor activation and B cell proliferation. This knowledge can identify IgAVN patients at a greater risk for adverse outcome and increase the evidence for treatment recommendations.

免疫球蛋白A血管炎性肾炎(IgAVN)的临床谱从相对常见的短暂性镜下血尿和/或低度蛋白尿到肾病或肾病综合征、快速进行性肾小球肾炎,甚至肾衰竭。临床和实验研究表明了一种多因素的发病机制:感染触发因素、IgA1糖基化受损、补体激活、Toll样受体激活和B细胞增殖。这些知识可以确定IgAVN患者不良反应风险更大,并增加治疗建议的证据。
{"title":"Immunoglobulin A vasculitis nephritis: Current understanding of pathogenesis and treatment.","authors":"Michela Amatruda,&nbsp;Nicolina Stefania Carucci,&nbsp;Roberto Chimenz,&nbsp;Giovanni Conti","doi":"10.5527/wjn.v12.i4.82","DOIUrl":"https://doi.org/10.5527/wjn.v12.i4.82","url":null,"abstract":"<p><p>The clinical spectrum of immunoglobulin A vasculitis nephritis (IgAVN) ranges from the relatively common transitory microscopic hematuria and/or low-grade proteinuria to nephritic or nephrotic syndrome, rapidly progressive glomerulonephritis, or even renal failure. Clinical and experimental studies have shown a multifactor pathogenesis: Infection triggers, impaired glycosylation of IgA1, complement activation, Toll-like-receptor activation and B cell proliferation. This knowledge can identify IgAVN patients at a greater risk for adverse outcome and increase the evidence for treatment recommendations.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"12 4","pages":"82-92"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/5f/WJN-12-82.PMC10520755.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41175358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of simulation in kidney stone disease: A systematic review of literature trends in the 26 years. 模拟在肾结石疾病中的作用:26年来文献趋势的系统综述。
Pub Date : 2023-09-25 DOI: 10.5527/wjn.v12.i4.104
Carlotta Nedbal, Victoria Jahrreiss, Clara Cerrato, Amelia Pietropaolo, Andrea Galosi, Domenico Veneziano, Panagiotis Kallidonis, Bhaskar K Somani

Background: Minimally invasive techniques for treatment of urinary stones requires expertise, experience and endoscopic skills. Simulators provide a low-stress and low-risk environment while providing a realistic set-up and training opportunities.

Aim: To report the publication trend of 'simulation in urolithiasis' over the last 26 years.

Methods: Research of all published papers on "Simulation in Urolithiasis" was performed through PubMed database over the last 26 years, from January 1997 to December 2022. Papers were labelled and divided in three subgroups: (1) Training papers; (2) Clinical simulation application or surgical procedures; and (3) Diagnostic radiology simulation. Each subgroup was then divided into two 13-year time periods to compare and identify the contrast of different decades: period-1 (1997-2009) and period-2 (2010-2022).

Results: A total of 168 articles published on the application of simulation in urolithiasis over the last 26 years (training: n = 94, surgical procedures: n = 66, and radiology: n = 8). The overall number of papers published in simulation in urolithiasis was 35 in Period-1 and 129 in Period-2, an increase of +269% (P = 0.0002). Each subgroup shows a growing trend of publications from Period-1 to Period-2: training papers +279% (P = 0.001), surgical simulations +264% (P = 0.0180) and radiological simulations +200% (P = 0.2105).

Conclusion: In the last decades there has been a step up of papers regarding training protocols with the aid of various simulation devices, with simulators now a part of training programs. With the development of 3D-printed and high-fidelity models, simulation for surgical procedure planning and patients counseling is also a growing field and this trend will continue to rise in the next few years.

背景:微创技术治疗尿路结石需要专业知识、经验和内镜技术。模拟器提供了一个低压力和低风险的环境,同时提供了现实的设置和培训机会。目的:报道《尿石症模拟》26年来的出版趋势。方法:从1997年1月到2022年12月,通过PubMed数据库对过去26年中发表的所有关于“泌尿系结石模拟”的论文进行研究。论文被标记并分为三个小组:(1)培训论文;(2) 临床模拟应用或外科手术;以及(3)放射学诊断模拟。然后将每个亚组分为两个13年的时间段,以比较和确定不同几十年的对比:第一阶段(1997-2009)和第二阶段(2010-2022)。结果:在过去26年中,共发表了168篇关于模拟在尿石症中的应用的文章(培训:n=94,外科手术:n=66,放射学:n=8)。在尿石症模拟中发表的论文总数在第1期为35篇,在第2期为129篇,增加了+269%(P=0.0002)。每个亚组都显示出从第1期到第2期发表论文的增长趋势:训练论文+279%(P=0.001),外科模拟+264%(P=0.0180)和放射学模拟+200%(P=0.02105)。结论:在过去的几十年里,借助各种模拟设备,关于训练协议的论文越来越多,模拟器现在是训练计划的一部分。随着3D打印和高保真模型的发展,外科手术计划和患者咨询的模拟也是一个不断发展的领域,这一趋势将在未来几年继续上升。
{"title":"Role of simulation in kidney stone disease: A systematic review of literature trends in the 26 years.","authors":"Carlotta Nedbal, Victoria Jahrreiss, Clara Cerrato, Amelia Pietropaolo, Andrea Galosi, Domenico Veneziano, Panagiotis Kallidonis, Bhaskar K Somani","doi":"10.5527/wjn.v12.i4.104","DOIUrl":"10.5527/wjn.v12.i4.104","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive techniques for treatment of urinary stones requires expertise, experience and endoscopic skills. Simulators provide a low-stress and low-risk environment while providing a realistic set-up and training opportunities.</p><p><strong>Aim: </strong>To report the publication trend of 'simulation in urolithiasis' over the last 26 years.</p><p><strong>Methods: </strong>Research of all published papers on \"Simulation in Urolithiasis\" was performed through PubMed database over the last 26 years, from January 1997 to December 2022. Papers were labelled and divided in three subgroups: (1) Training papers; (2) Clinical simulation application or surgical procedures; and (3) Diagnostic radiology simulation. Each subgroup was then divided into two 13-year time periods to compare and identify the contrast of different decades: period-1 (1997-2009) and period-2 (2010-2022).</p><p><strong>Results: </strong>A total of 168 articles published on the application of simulation in urolithiasis over the last 26 years (training: <i>n</i> = 94, surgical procedures: <i>n</i> = 66, and radiology: <i>n</i> = 8). The overall number of papers published in simulation in urolithiasis was 35 in Period-1 and 129 in Period-2, an increase of +269% (<i>P</i> = 0.0002). Each subgroup shows a growing trend of publications from Period-1 to Period-2: training papers +279% (<i>P</i> = 0.001), surgical simulations +264% (<i>P</i> = 0.0180) and radiological simulations +200% (<i>P</i> = 0.2105).</p><p><strong>Conclusion: </strong>In the last decades there has been a step up of papers regarding training protocols with the aid of various simulation devices, with simulators now a part of training programs. With the development of 3D-printed and high-fidelity models, simulation for surgical procedure planning and patients counseling is also a growing field and this trend will continue to rise in the next few years.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"12 4","pages":"104-111"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/7c/WJN-12-104.PMC10520753.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World journal of nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1